Wuxi Pharmaceutical Ming Kand conducted a series of share repurchases of A shares between March 8 and April 24, 2024. According to reports disclosed by the Company, the Company repurchased several shares during the above periods, with a detailed record of the number of shares repurchased and the date of the change. For example, 937,079 shares were repurchased on March 11, and 475,800 shares were repurchased on April 24. The price of each repurchase is different from the market price, sometimes below the market price and sometimes higher than the market price. These repurchases are conducted in accordance with the relevant rules at the Shanghai Stock Exchange. THIS SERIES OF SHARE REPURCHASES BY PHARMACEUTICALS SHOWS THE COMPANY'S CONFIDENCE IN ITS STOCK PRICE AND MAY AFFECT THE MARKET'S ASSESSMENT OF THE COMPANY'S STOCK.

Wuxi Pharmaceutical Ming Kand conducted a series of share repurchases of A shares between March 8 and April 24, 2024. According to reports disclosed by the Company, the Company repurchased several shares during the above periods, with a detailed record of the number of shares repurchased and the date of the change. For example, 937,079 shares were repurchased on March 11, and 475,800 shares were repurchased on April 24. The price of each repurchase is different from the market price, sometimes below the market price and sometimes higher than the market price. These repurchases are conducted in accordance with the relevant rules at the Shanghai Stock Exchange. THIS SERIES OF SHARE REPURCHASES BY PHARMACEUTICALS SHOWS THE COMPANY'S CONFIDENCE IN ITS STOCK PRICE AND MAY AFFECT THE MARKET'S ASSESSMENT OF THE COMPANY'S STOCK.